Israel - engelsk - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - suspension for injection - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

Israel - engelsk - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - suspension for injection - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

Israel - engelsk - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - suspension for injection - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - insulin human - unknown - insulin human active 0.0 - active constituent

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; sodium hydroxide; zinc chloride; phenol; hydrochloric acid; glycerol; water for injections; protamine sulfate; metacresol - the treatment of insulin-requiring diabetes.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; phenol; hydrochloric acid; water for injections; metacresol; zinc chloride; protamine sulfate; sodium hydroxide; glycerol - the treatment of insulin-requiring diabetes.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: hydrochloric acid; zinc chloride; protamine sulfate; sodium hydroxide; metacresol; dibasic sodium phosphate dihydrate; water for injections; glycerol; phenol - the treatment of insulin-requiring diabetes.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 50 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; glycerol; metacresol; hydrochloric acid; zinc chloride; sodium hydroxide; phenol; water for injections; protamine sulfate - the treatment of insulin-requiring diabetes.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; glycerol; hydrochloric acid; zinc chloride; water for injections; sodium hydroxide - the treatment of insulin-requiring diabetes.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; sodium hydroxide; glycerol; hydrochloric acid; water for injections; zinc chloride - the treatment of insulin-requiring diabetes.